First Time Loading...

LumiraDx Ltd
NASDAQ:LMDX

Watchlist Manager
LumiraDx Ltd Logo
LumiraDx Ltd
NASDAQ:LMDX
Watchlist
Price: 0.016 USD Market Closed
Updated: Apr 26, 2024

Intrinsic Value

LMDX's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

LumiraDX Ltd. engages in the provision of next-generation POC diagnostic company, which focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare pr... [ Read More ]

The intrinsic value of one LMDX stock under the Base Case scenario is 0.02 USD. Compared to the current market price of 0.016 USD, LumiraDx Ltd is Undervalued by 22%.

Key Points:
LMDX Intrinsic Value
Base Case
0.02 USD
Undervaluation 22%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
LumiraDx Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling LMDX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
LumiraDx Ltd

Provide an overview of the primary business activities
of LumiraDx Ltd.

What unique competitive advantages
does LumiraDx Ltd hold over its rivals?

What risks and challenges
does LumiraDx Ltd face in the near future?

Summarize the latest earnings call
of LumiraDx Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for LumiraDx Ltd.

Provide P/S
for LumiraDx Ltd.

Provide P/E
for LumiraDx Ltd.

Provide P/OCF
for LumiraDx Ltd.

Provide P/FCFE
for LumiraDx Ltd.

Provide P/B
for LumiraDx Ltd.

Provide EV/S
for LumiraDx Ltd.

Provide EV/GP
for LumiraDx Ltd.

Provide EV/EBITDA
for LumiraDx Ltd.

Provide EV/EBIT
for LumiraDx Ltd.

Provide EV/OCF
for LumiraDx Ltd.

Provide EV/FCFF
for LumiraDx Ltd.

Provide EV/IC
for LumiraDx Ltd.

Show me price targets
for LumiraDx Ltd made by professional analysts.

What are the Revenue projections
for LumiraDx Ltd?

How accurate were the past Revenue estimates
for LumiraDx Ltd?

What are the Net Income projections
for LumiraDx Ltd?

How accurate were the past Net Income estimates
for LumiraDx Ltd?

What are the EPS projections
for LumiraDx Ltd?

How accurate were the past EPS estimates
for LumiraDx Ltd?

What are the EBIT projections
for LumiraDx Ltd?

How accurate were the past EBIT estimates
for LumiraDx Ltd?

Compare the revenue forecasts
for LumiraDx Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of LumiraDx Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of LumiraDx Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of LumiraDx Ltd compared to its peers.

Compare the P/E ratios
of LumiraDx Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing LumiraDx Ltd with its peers.

Analyze the financial leverage
of LumiraDx Ltd compared to its main competitors.

Show all profitability ratios
for LumiraDx Ltd.

Provide ROE
for LumiraDx Ltd.

Provide ROA
for LumiraDx Ltd.

Provide ROIC
for LumiraDx Ltd.

Provide ROCE
for LumiraDx Ltd.

Provide Gross Margin
for LumiraDx Ltd.

Provide Operating Margin
for LumiraDx Ltd.

Provide Net Margin
for LumiraDx Ltd.

Provide FCF Margin
for LumiraDx Ltd.

Show all solvency ratios
for LumiraDx Ltd.

Provide D/E Ratio
for LumiraDx Ltd.

Provide D/A Ratio
for LumiraDx Ltd.

Provide Interest Coverage Ratio
for LumiraDx Ltd.

Provide Altman Z-Score Ratio
for LumiraDx Ltd.

Provide Quick Ratio
for LumiraDx Ltd.

Provide Current Ratio
for LumiraDx Ltd.

Provide Cash Ratio
for LumiraDx Ltd.

What is the historical Revenue growth
over the last 5 years for LumiraDx Ltd?

What is the historical Net Income growth
over the last 5 years for LumiraDx Ltd?

What is the current Free Cash Flow
of LumiraDx Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for LumiraDx Ltd.

Financials

Balance Sheet Decomposition
LumiraDx Ltd

Current Assets 175.3m
Cash & Short-Term Investments 25.3m
Receivables 64.8m
Other Current Assets 85.2m
Non-Current Assets 165.5m
Long-Term Investments 11.5m
PP&E 120.9m
Intangibles 32.3m
Other Non-Current Assets 800k
Current Liabilities 89m
Accounts Payable 66m
Other Current Liabilities 23m
Non-Current Liabilities 466.4m
Long-Term Debt 393.9m
Other Non-Current Liabilities 72.5m
Efficiency

Earnings Waterfall
LumiraDx Ltd

Revenue
126.5m USD
Cost of Revenue
-228.4m USD
Gross Profit
-101.9m USD
Operating Expenses
-203.2m USD
Operating Income
-305.1m USD
Other Expenses
-32.9m USD
Net Income
-338m USD

Free Cash Flow Analysis
LumiraDx Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

LMDX Profitability Score
Profitability Due Diligence

LumiraDx Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Exceptional ROE
Negative 1-Year Revenue Growth
Negative Operating Income
34/100
Profitability
Score

LumiraDx Ltd's profitability score is 34/100. The higher the profitability score, the more profitable the company is.

LMDX Solvency Score
Solvency Due Diligence

LumiraDx Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Short-Term Solvency
Long-Term Solvency
58/100
Solvency
Score

LumiraDx Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

LMDX Price Targets Summary
LumiraDx Ltd

There are no price targets for LMDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

LMDX Price
LumiraDx Ltd

1M 1M
+0%
6M 6M
-88%
1Y 1Y
-97%
3Y 3Y
-100%
5Y 5Y
-100%
10Y 10Y
-100%
Annual Price Range
0.016
52w Low
0.0086
52w High
0.6
Price Metrics
Average Annual Return -48.87%
Standard Deviation of Annual Returns 58.43%
Max Drawdown -100%
Shares Statistics
Market Capitalization 347.3m USD
Shares Outstanding 21 706 714 434
Percentage of Shares Shorted 2.38%

LMDX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

LumiraDx Ltd Logo
LumiraDx Ltd

Country

United Kingdom

Industry

Health Care

Market Cap

347.3m USD

Dividend Yield

0%

Description

LumiraDX Ltd. engages in the provision of next-generation POC diagnostic company, which focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need, thereby enabling more informed medical decisions to improve health outcomes. The firm is focused on transforming community-based healthcare by providing critical diagnostic information to healthcare providers at the point of need. The firm has developed and launched LumiraDx Platform, a platform which is an integrated system comprised of a small, point of care (POC) instrument, microfluidic test strips, and secure digital connectivity. The firm has developed five diagnostic tests which includes SARS-CoV-2 antigen, SARS-CoV-2 antigen pool, SARS-CoV-2 antibody, International Normalized Ratio (INR) test, and D-Dimer test. The company has also developed two rapid COVID-19 reagent testing kits for use on open molecular systems, LumiraDx SARS-CoV-2 RNA STAR and SARS-CoV-2 RNA STAR. Its platform has a pipeline of approximately more than 30 tests in various stages of development for the community-based healthcare settings.

Contact

London
3 More London Riverside
+441786430411.0
https://www.lumiradx.com/

IPO

2021-03-09

Employees

1 513

Officers

Co-Founder, Chairman & CEO
Mr. Ron Zwanziger
Co-Founder, CTO & Director
Dr. David Scott Ph.D.
Co-Founder, Chief Scientist & Director
Dr. Jerome F. McAleer Ph.D.
CFO & VP of Global Operations
Mr. Dorian LeBlanc CPA
Exec. VP & Gen. Counsel
Ms. Veronique Ameye
VP of Communications
Ms. Colleen McMillen
Show More
National Sales Director - UK
Andy Ward
Pres of North American Commercial Operations
Mr. Peter Scheu
Chief Commercial Officer
Mr. David Walton DMS
Chief Innovation Officer
Dr. Nigel Lindner
Show Less

See Also

Discover More
What is the Intrinsic Value of one LMDX stock?

The intrinsic value of one LMDX stock under the Base Case scenario is 0.02 USD.

Is LMDX stock undervalued or overvalued?

Compared to the current market price of 0.016 USD, LumiraDx Ltd is Undervalued by 22%.